Digital Pathology, AI & Clinical Trials: A Conversation with Monika Lamba Saini

Join us for this Pathology News podcast episode as Sidney Ocanagil-Tunstall speaks with Monika Lamba Saini about the growing impact of digital pathology, clinical trials, and AI, exploring how these technologies are reshaping workflows, biomarker discovery, and drug development.In this episode, Sidney speaks with Monika Lamba Saini, Global Translational Pathology Leader, who brings over 20 years of experience across clinical pathology, research, and clinical trials. She shares her perspective on the evolution of pathology from traditional microscopy to a more digital, data-driven discipline, highlighting how adoption accelerated during COVID-19 with the shift to remote slide review and virtual training.They discuss how digital pathology is improving clinical trials through centralized review, streamlined workflows, and enhanced global collaboration, while also reducing logistical challenges such as physical slide transport. Monika also explains how AI is transforming biomarker analysis, enabling more precise, reproducible, and scalable insights at cellular and subcellular levels, and supporting advances in translational research and drug development.Finally, the conversation looks ahead to the future of pathology, addressing ongoing challenges around validation, regulation, and data governance, while emphasizing a hybrid model where AI augments human expertise. Overall, the episode highlights a shift toward more efficient, collaborative, and patient-focused clinical trials driven by digital innovation.